Meningitis bacteriana en ambientes de bajos recursos

1. Pentavalent vaccine support. Available at: www.gavialliance.org/support/nvs/pentavalent. Accessed October 1, 2014.
2. Delrieu I, Yaro S, Tamekloé TA, et al. Emergence of epidemic Neisseria meningitidis serogroup X
meningitis in Togo and Burkina Faso. PLoS One. 2011; 6:e19513.
3. Emergence of W135 Meningococcal Disease - libdoc. who.int.whqlibdoc.who.int/hq/2002/WHO_ CDS_CSR_GAR_2002.1.pdf WHO/CDS/CSR/GAR/2002.1. Emergence of W135 Meningococcal Disease. Report of a WHO Consultation Geneva 17–18 September 2001. Accessed October 2014.
4. CDC. Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for revaccination of persons at prolonged increased risk for meningococcal disease. MMWR. 2009; 58:1042–1043.
5. Everett DB, Mukaka M, Denis B, et al. Ten years of surveillance for invasive Streptococcus pneumoniae during the era of antiretroviral scale-up and cotrimoxazole prophylaxis in Malawi. PLoS
One. 2011; 6:e17765.
6. Pocket Book of Hospital Care for Children: guidelines for the management of common childhood illnesses. 2nd edition. 2103. WHO: Geneva.
http://apps.who. int/iris/bitstream/10665/81170/1/9789241548373_eng.pdf. Accessed July 29, 2014.
7. Falade AG, Lagunju IA, Bakare RA, et al. Invasive pneumococcal disease in children aged <5 years admitted to 3 urban hospitals in Ibadan, Nigeria. Clin Infect Dis. 2009; 48(Suppl 2):S190–S196.
8. Kisakye A, Makumbi I, Nansera D, et al. Surveillance for Streptococcus pneumoniae meningitis in children aged <5 years: implications for immunization in Uganda. Clin Infect Dis. 2009; 48(Suppl 2):S153–S161.
9. Swann O, Everett DB, Furyk JS, et al. Bacterial meningitis in Malawian infants <2 months of age: etiology and susceptibility to World Health Organization first-line antibiotics. Pediatr Infect Dis J. 2014; 33:560–565
10. Molyneux E, Nizami SQ, Saha S, et al; CSF 5 Study Group. A double blind randomised study
comparing 5 vs 10 days of ceftriaxone therapy for bacterial meningitis in children. The Lancet. 2011; 377:1837–1845.
11. Molyneux EM, Walsh AL, Forsyth H, et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet. 2002; 360:211–218.
12. Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2013; 6:CD004405.
13. Peltola H, Roine I, Fernández J, et al. Adjuvant glycerol and/or dexamethasone to improve the
outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebocontrolled trial. Clin Infect Dis. 2007; 45:1277–1286.
14. Molyneux EM, Kawaza K, Phiri A, et al. Glycerol and acetaminophen as adjuvant therapy did not affect the outcome of bacterial meningitis in Malawian children. Pediatr Infect Dis J. 2014; 33:214–216.
15. Maconochie IK, Bhaumik S. Fluid therapy for acute bacterial meningitis. Cochrane Database Syst Rev. 2014; 5:CD004786.
16. Roine I, Weisstaub G, Peltola H; LatAm Bacterial Meningitis Study Group. Influence of malnutrition on the course of childhood bacterial meningitis. Pediatr Infect Dis J. 2010; 29:122–125.